# Domperidone as a Treatment for Dopamine Agonist-induced Peripheral Edema in Patients With Parkinson's Disease

> **NCT00305331** · PHASE2 · TERMINATED · sponsor: **University Health Network, Toronto** · enrollment: 25 (estimated)

## Conditions studied

- Parkinson's Disease
- Peripheral Edema

## Interventions

- **DRUG:** Domperidone (drug)

## Key facts

- **NCT ID:** NCT00305331
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-03
- **Primary completion:** 2008-07
- **Final completion:** 2008-09
- **Target enrollment:** 25 (ESTIMATED)
- **Why stopped:** lack of recruitment
- **Last updated:** 2012-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00305331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00305331, "Domperidone as a Treatment for Dopamine Agonist-induced Peripheral Edema in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00305331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*